skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: EZB Electronic Journals Library remover idioma: Russo remover Oxford Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

Cassidy, J. ; Twelves, C. ; Van Cutsem, E. ; Hoff, P. ; Bajetta, E. ; Boyer, M. ; Bugat, R. ; Burger, U. ; Garin, A. ; Graeven, U. ; McKendrick, J. ; Maroun, J. ; Marshall, J. ; Osterwalder, B. ; Pérez-Manga, G. ; Rosso, R. ; Rougier, P. ; Schilsky, R. L.

Annals of oncology, 2002-04, Vol.13 (4), p.566-575 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Cohn, A.L. ; Tabernero, J. ; Maurel, J. ; Nowara, E. ; Sastre, J. ; Chuah, B.Y.S. ; Kopp, M.V. ; Sakaeva, D.D. ; Mitchell, E.P. ; Dubey, S. ; Suzuki, S. ; Hei, Y.-J. ; Galimi, F. ; McCaffery, I. ; Pan, Y. ; Loberg, R. ; Cottrell, S. ; Choo, S.-P.

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Pozzo, C. ; Barone, C. ; Szanto, J. ; Padi, E. ; Peschel, C. ; Bükki, J. ; Gorbunova, V. ; Valvere, V. ; Zaluski, J. ; Biakhov, M. ; Zuber, E. ; Jacques, C. ; Bugat, R.

Annals of oncology, 2004-12, Vol.15 (12), p.1773-1781 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
4
A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer
A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer

Bouzid, K. ; Khalfallah, S. ; Tujakowski, J. ; Piko, B. ; Purkalne, G. ; Plate, S. ; Padrik, P. ; Serafy, M. ; Pshevloutsky, E. M. ; Boussard, B.

Annals of oncology, 2003-07, Vol.14 (7), p.1106-1114 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.